| Announce Date | 10/30/2025 |
| EPS Normalized Actual | $0.41 (Beat by $0.02) |
| EPS GAAP Actual | $0.41 (Beat by $0.02) |
| Revenue Actual | $2.085B |
| Revenue Surprise | Beat by $2085M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $0.47544 |
| EPS GAAP Estimate | $0.47544 |
| Revenue Estimate | $1.827248832B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2028 | 2.91 | 15.56 | 2.87921 | 2.94123 | 1 |
| Dec 2028 | 1.94 | 23.34 | 1.89415 | 1.97322 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.2 | -0.42628 | 2.085B | 12.42% | 103.19M |
| FQ2 2025 (Jun 2025) | 0.17 | 0.17 | 1.99B | 13.07% | 1990M |
| FQ1 2025 (Mar 2025) | 0.11 | 0.11 | 1.719B | 6.86% | 1719M |
| FQ4 2024 (Dec 2024) | 0.24 | 0.24 | 1.861B | 5.48% | 1861M |
| FQ3 2024 (Sep 2024) | 0.25 | 0.25 | 1.826B | 2.3% | 1826M |
| FQ1 2019 (Mar 2019) | 0.0491 | 0.0491 | 0.922B | 100% | 922M |
| FQ2 2024 (Jun 2024) | 0.25 | 0.25 | 1.73B | -2.37% | 1730M |
| FQ1 2024 (Mar 2024) | -1.34 | -1.34 | 1.601B | 100% | 1601M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
0.47544
Consensus Revenue Estimates
1.827248832B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Oct 2027) | 0.7169 | -- | 0.7129 | 0.72243 | 0 |
| FQ3 2027 (Jul 2027) | 0.6257 | -- | 0.62221 | 0.63052 | 0 |
| FQ2 2027 (Jun 2027) | 0.6257 | -- | 0.61824 | 0.63403 | 2 |
| FQ1 2027 (Mar 2027) | 0.4386 | -- | 0.4386 | 0.4386 | 2 |
| FQ4 2026 (Oct 2026) | 0.67168 | -- | 0.66794 | 0.67686 | 0 |
| FQ3 2026 (Jul 2026) | 0.60083 | 66.71 | 0.59748 | 0.60546 | 0 |
| FQ2 2026 (Jun 2026) | 0.6257 | 72.83 | 0.61824 | 0.63403 | 3 |
| FQ1 2026 (Mar 2026) | 0.47544 | 76.86 | 0.47544 | 0.47544 | 2 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Oct 2027) | 2.08B | -- | 2.07B | 2.09B | 0 |
| FQ3 2027 (Jul 2027) | 2.01B | -- | 2B | 2.02B | 0 |
| FQ2 2027 (Jun 2027) | 2.01B | -- | 1.99B | 2.03B | 2 |
| FQ1 2027 (Mar 2027) | 1.76B | -- | 1.76B | 1.76B | 4 |
| FQ4 2026 (Oct 2026) | 2.06B | -- | 2.05B | 2.07B | 0 |
| FQ3 2026 (Jul 2026) | 1.97B | -5.89 | 1.96B | 1.98B | 0 |
| FQ2 2026 (Jun 2026) | 2.01B | 0.93 | 1.99B | 2.03B | 2 |
| FQ1 2026 (Mar 2026) | 1.83B | 5.92 | 1.83B | 1.83B | 4 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
2
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.62628 | 0.2 | -0.42628 | -213.14% |
| FQ2 2025 (Jun 2025) | 0.17 | 0.17 | 100% | |
| FQ1 2025 (Mar 2025) | 0.11 | 0.11 | 100% | |
| FQ4 2024 (Dec 2024) | 0.24 | 0.24 | 100% | |
| FQ3 2024 (Sep 2024) | 0.25 | 0.25 | 100% | |
| FQ1 2019 (Mar 2019) | 0.0491 | 0.0491 | 100% | |
| FQ2 2024 (Jun 2024) | 0.25 | 0.25 | 100% | |
| FQ1 2024 (Mar 2024) | -1.34 | -1.34 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $1.98B | $2.09B | $103.19M | 4.95% |
| FQ2 2025 (Jun 2025) | $0B | $1.99B | $1990M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $1.72B | $1719M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $1.86B | $1861M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $1.83B | $1826M | 100% |
| FQ1 2019 (Mar 2019) | $0B | $0.92B | $922M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $1.73B | $1730M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $1.6B | $1601M | 100% |